Résultats de la recherche - 5 results
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaksAbstract
Basil Britto; Le Mercier, Marie; Coppens, Jasmine; Matheeussen, Veerle; Goossens, Herman; Martens, Geert A.; Swaerts, Koen; Van Hoecke, Frederik; Desmet, Dieter; Descheemaeker, Patrick; Bogaerts, Pierre; ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Vanhoutte; Bart Peeters; Silke Raats; Isolde Van der Massen; Sven De Keersmaecker; Yana Debie; Manon Huizing; Pieter Pannus; Kristof Y Neven; Ariën, Kevin K; Geert A Martens; Marc Van den Bulcke; Ella Roelant; ...
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
A Martens; Van Esbroeck, Marjan; Maria Goossens; Arnaud Marchant; Koen Bartholomeeusen; I Desombere Source: NPJ Vaccines, Volume 7, Issue 1 (2022) Abstract: We report the levels of neutralising antibodies ...
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
Y Debie; M Huizing; Pieter Pannus; K Neven; K K Ariën; G. A. Martens; Marc Van den Bulcke; E Roelant; I Desombere; S Anguille; Maria Goossens; T Vandamme; P van Dam Source: ESMO Open, Volume 6, Issue ...
Differences among mumps virus surface proteins between genotype G and other genotypes and their potential effect on mumps virus immunity and pathogenesis.
Publication Type: Scientific poster, presentation or proceeding Authors: T. Vermeire; Gouma,S.; Steven Van Gucht; Martens,L.; Veronik Hutse; Cremer,J.; G. Leroux-Roels; Koopmans,M.; Van ...